Knee Injections for Obese Patients With Knee Arthritis
ConditionOsteoarthritis of Knee
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age55-85
SponsorMayo Clinic
About this trial
The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
Eligibility criteria
Qualifiers
None
Disqualifiers
BMI < 30 kg/m2
Uncontrolled diabetics with a hemoglobin A1c > 8%
No other treatment within the time frame of the study.
Patients that are undergoing physical therapy at the time of the study.
Trial design
Treatments tested in this trial
- Triamcinolone Acetonide Low Dose
- Triamcinolone Acetonide Standard Dose
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov